APOE and Neurofibrillary tangles: We were unable to examine the effect of genetic data and tau/amyloid profiles on cluster membership, but previous researchers have suggested that atypical AD patients had lower probability of APOE ε4 and less severe neurofibrillary tangle (tau) pathology, which may have an impact on tau-targeting therapies in AD [7].